RESI Europe 2025

The international conference Redefining Early Stage Investments (RESI), organized by Life Science Nation (LSN), was held in Barcelona from April 1 to 3, 2025, with the goal of connecting early-stage startups with international investors to establish strategic alliances. This boutique conference chose Barcelona to host its second edition thanks to the collaboration of Biocat, the Barcelona City Council, and the Government of Catalonia.

The event brought together over 450 attendees from nearly 350 companies worldwide. The first day of the conference was held in person and included partnering sessions and activities such as the Healthtech Market Access Panel, organized by Biocat. The following two days took place virtually, offering spaces for pitches, workshops, and sector-leading conferences.

• It was the only event with a 1:1 ratio of investors to startups. RESI EUROPE Barcelona brought together between 250 and 300 international investors. These investors were part of a global network and were seeking opportunities in seed, Series A, and Series B stages.
   
• The event was dedicated to global investors and licensing partners from the pharmaceutical, medical device, diagnostics, and digital health sectors.
   
• Roundtables and workshops: offered insights into the latest market trends, investment strategies, and best business practices.
   
• The Innovators Pitch Challenge (IPC): ensured that each startup could present to a panel of investors aligned with their development stage and product. Each participant received written feedback from the investors.
   
• Networking: RESI was not only a platform for exchanging investment opportunities, but also a space for collaboration and innovation. New synergies and strategic alliances were created with other stakeholders through the partnering platform.
   
• Sponsorship package: offered multiple benefits to increase visibility and connections during the conference.

• 1st Place – Valued at €12,000 – Awarded to Mowoot
  Free entry to 3 RESI* events of their choice (up to 2 tickets per event).
   
• 2nd Place – Valued at €8,000 – Awarded to Darwin Biomed
  Free entry to 2 RESI* events of their choice (up to 2 tickets per event).
   
• 3rd Place – Valued at €4,000 – Awarded to Opportunity Health
  Free entry to 1 RESI* event of their choice (up to 2 tickets per event).

The prizes include access to other annual editions of the conference around the world, thus maximizing networking and investment opportunities through the LSN network. The awards were presented by Dennis Ford, President of Life Science Nation (LSN); Xavier Mayo, Head of the Barcelona Investment Office at Barcelona City Council; and Robert Fabregat, Director General of Biocat.

Round Table

Healthtech Market Access Panel Discussion

It explored the challenges and strategies for achieving market access for digital health innovations, focusing on regulatory barriers, coverage, coding, reimbursement, and adoption pathways, as well as the role of data and digital tools in healthcare.

01/04/2025

11:00 AM - 11:50 AM

Hotel InterContinental Barcelona

 Organized by Biocat 

Moderator:

• Carmen Ríos, CEO Doctomatic

Speakers:

• Meike Bomhof, VP Market Access of Avania.
• Ana Maiques, CEO Neuroelectrics.
• Francisco Rodríguez, Medical Device Manager and Lead Auditor of Asphalion.

01/04/2025

5 PM -7 PM

Hotel InterContinental Barcelona (Terrace Garden)

5 PM Welcome from Dennis Ford, Founder and CEO of LSN

5:10 PM Speech by Xavier Mayo, Head of the Barcelona Investment Office – BIO, Barcelona City Council

5:20 PM Presentation of the Innovator’s Pitch Challenge Awards by Dennis Ford, Xavier Mayo and Robert Fabregat (General Director of Biocat)

6 PM Cocktail Networking.

The alliance to bring the international conference Redefining Early Stage Investments (RESI) to Barcelona in 2025 offered, once again, exclusive benefits for organizations in the BioRegion of Catalonia.